Predicting operative mortality after surgery for ischemic cardiomyopathy

Area of Science:

• Cardiology
• Cardiac Surgery
• Heart Failure Research

Background:

• Ischemic cardiomyopathy is a leading cause of heart failure, often lacking clear treatment algorithms.
• Surgical interventions like coronary artery bypass grafting (CABG), CABG with mitral valve repair (CABG/MVR), and left ventricular remodeling (LVR) are considered.
• The impact of additional procedures on operative risk and mortality requires further investigation.

Purpose of the Study:

• To assess the operative risks and mortality associated with different surgical strategies for ischemic cardiomyopathy.
• To determine if additional procedures (MVR, LVR) increase the risk compared to CABG alone.
• To identify preoperative variables that influence surgical outcomes.

Main Methods:

• Retrospective analysis of 382 patients undergoing cardiac surgery between 2000 and 2006.
• Inclusion criteria: CABG with ejection fraction < 35%, ischemic mitral regurgitation, or LVR.
• Analysis of Society of Thoracic Surgeons database for risks, complications, outcomes, revascularization completeness, and procedure types.

Main Results:

• Overall operative mortality was 7.9%. Mortality rates were 9.1% for CABG, 8.2% for CABG/MVR, and 3.1% for LVR.
• Preoperative risk factors for mortality included diabetes, cerebrovascular disease, and renal dysfunction.
• Emergency operations and intra-aortic balloon pump use were associated with significantly increased mortality.

Conclusions:

• Mitral valve repair and left ventricular remodeling do not add to the operative risk of CABG in ischemic cardiomyopathy.
• Preoperative comorbidities and the urgency of the operation are the primary drivers of increased operative mortality.